Anti P200 Pemphigoid C5681099
Rare autoimmune blistering skin condition. Causes tense blisters and skin irritation. Requires dermatology care and immunosuppressive treatment.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Topical corticosteroids
High-potency topical corticosteroids are applied to affected skin areas to reduce inflammation and blister formation. This is typically the first-line approach for localized disease.
Systemic immunosuppressants
Oral immunosuppressants such as azathioprine or mycophenolate mofetil may be prescribed for widespread or refractory disease to suppress the autoimmune response.
Additional treatment options
Phototherapy
Narrowband UVB phototherapy can be used as an adjunct treatment for patients who do not respond adequately to topical therapies alone.
procedureGentle skin care regimen
Using mild, fragrance-free cleansers and moisturizers helps maintain skin barrier function and reduces irritation that may trigger flares.
lifestyleRegular dermatology follow-up
Periodic clinical examinations and laboratory testing to monitor disease activity, treatment response, and screen for potential complications.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti P200 Pemphigoid C5681099?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schmidt E, Zillikens D. Diagnosis and treatment of anti-p200 pemphigoid. J Am Acad Dermatol. 2018;78(3):523-535.
Murrell DF, Marinovic B, Caux F, et al. Definitions and outcome measures for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Br J Dermatol. 2020;183(4):655-664.
Dainichi T, Koga H, Furumura T, et al. Anti-p200 pemphigoid: diagnostic and therapeutic challenges. J Eur Acad Dermatol Venereol. 2019;33(11):e423-e425.
B现象er JW, Amber KT. Direct immunofluorescence microscopy in the diagnosis of autoimmune bullous diseases. Clin Dermatol. 2021;39(2):231-241.
Medication Comparisons
Compare medications used to treat Anti P200 Pemphigoid C5681099. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy